1. Antineoplastic drug contamination in the urine of Canadian healthcare workers.
- Author
-
Hon, Chun-Yip, Teschke, Kay, Shen, Hui, Demers, Paul, and Venners, Scott
- Subjects
URINALYSIS ,CYCLOPHOSPHAMIDE ,ANTINEOPLASTIC agents ,HEALTH risk assessment ,HOSPITAL medical staff ,OCCUPATIONAL hazards ,MEDICAL personnel - Abstract
Purpose: The purpose of this study was to quantify the urine concentration of non-metabolized cyclophosphamide (CP), a commonly administered antineoplastic drug, among potentially exposed Canadian healthcare workers and to identify factors associated with the drug concentration levels. Methods: Participants were asked to provide two sets of 24-h urine samples (at two different sampling events), and the level of CP was quantified using high-performance liquid chromatography-tandem mass spectrometry. In addition to demographic information, participants were surveyed regarding their frequency of handling of antineoplastic drugs, safe drug handling training, and known contact with CP on their work shift. Descriptive and inferential statistical analyses were performed. A backward stepwise linear mixed effect model was conducted to identify the factors associated with urine concentration levels. Results: We collected 201 urine samples, and 55 % ( n = 111) had levels greater than the LOD of 0.05 ng/mL. The mean urinary CP concentration was 0.156 ng/mL, the geometric mean was 0.067 ng/mL, the geometric standard deviation was 3.18, the 75th percentile was 0.129 ng/mL, and the range was
- Published
- 2015
- Full Text
- View/download PDF